Edwards Lifesciences
1,276 hedge funds and large institutions have $46.4B invested in Edwards Lifesciences in 2024 Q1 according to their latest regulatory filings, with 159 funds opening new positions, 434 increasing their positions, 461 reducing their positions, and 106 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
10% more call options, than puts
Call options by funds: $431M | Put options by funds: $393M
0.74% more ownership
Funds ownership: 80.18% → 80.92% (+0.74%)
6% less repeat investments, than reductions
Existing positions increased: 434 | Existing positions reduced: 461
Holders
1,276
Holding in Top 10
14
Calls
$431M
Puts
$393M
Top Buyers
| 1 | +$425M | |
| 2 | +$256M | |
| 3 | +$250M | |
| 4 |
Holocene Advisors
New York
|
+$211M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$201M |
Top Sellers
| 1 | -$573M | |
| 2 | -$507M | |
| 3 | -$225M | |
| 4 |
SFFS
Stonehage Fleming Financial Services
St. Helier,
Jersey
|
-$175M |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
-$130M |